Breaking News Instant updates and real-time market news.

CBAY

CymaBay

$13.09

-0.35 (-2.60%)

07:15
04/13/18
04/13
07:15
04/13/18
07:15

CymaBay price target raised to $21 from $18 at H.C. Wainwright

H.C. Wainwright analyst Ed Arce raised his price target for CymaBay Therapeutics to $21 saying results from a second interim analysis of the ongoing one-year open-label Phase 2 study of seladelpar in primary biliary cholangitis patients are "strongly positive" and better than expected. The data show "robust and sustained" efficacy at 26 weeks, a clear dose response and reductions in pruritus, Arce tells investors in a research note. He believes seladelpar possesses the leading clinical profile to support second-line treatment. The analyst affirms a Buy rating on CymaBay.

  • 08

    May

CBAY CymaBay
$13.09

-0.35 (-2.60%)

03/28/18
LEER
03/28/18
NO CHANGE
Target $16
LEER
Outperform
More differentiating data at EASL can continue CymaBay momentum, says Leerink
Leerink analyst Joseph Schwartz expects a 6-month Phase 2 study update for CymaBay's (CBAY) seladelpar in primary biliary cholangitis to be reported at the International Liver Congress. The analyst notes CymaBay stock has enjoyed strong momentum since the preliminary 12-week data and he remains optimistic that seladelpar's profile will continue to look differentiated from Intercept's (ICPT) Ocaliva when it comes to safety/tolerability and efficacy in the second-line PBC treatment setting. The analyst reiterates an Outperform rating and $16 price target on CymaBay's shares.
04/05/18
CANT
04/05/18
NO CHANGE
Target $16
CANT
Overweight
CymaBay share demand to increase with index rebalance, says Cantor Fitzgerald
Cantor Fitzgerald's quants team predicts that CymaBay will be added to the Russell 2000 Index on June 22, analyst William Tanner tells investors in a research note. The firm estimates that passive trackers will need to buy 4.3M shares of the company. Tanner believes the Russell 2000 rebalancing could create increased demand for shares of CymaBay. The analyst has an Overweight rating on the stock with a $16 price target.
04/11/18
EVER
04/11/18
NO CHANGE
Target $35
EVER
Outperform
CymaBay seladelpar results in PBC 'highly compelling,' says Evercore ISI
Evercore ISI analyst Josh Schimmer noted that CymaBay announced results from its ongoing Phase 2 trial with seladelpar in patients with primary biliary cholangitis, or PBC, a day early due to a mix-up on the EASL website. He called the data "highly compelling," noting the clear dose response evidenced and a "very clean" safety profile. Schimmer added that the update increases his confidence in the outlook for seladelpar in PBC and he keeps an Outperform rating on CymaBay shares.
04/11/18
LEER
04/11/18
NO CHANGE
Target $20
LEER
Outperform
CymaBay price target raised to $20 from $16 at Leerink
Leerink analyst Joseph Schwartz raised CymaBay's price target to $20 from $16 following better than expected results from the ongoing Phase 2 study of seladelpar. Schwartz increased his PBC probability of success to 75% from 60% and reiterated his Outperform rating on CymaBay shares.

TODAY'S FREE FLY STORIES

ADBE

Adobe

$242.33

-6.56 (-2.64%)

11:55
10/15/18
10/15
11:55
10/15/18
11:55
Conference/Events
Adobe to hold a conference »

Adobe MAX is being held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

KRYS

Krystal Biotech

$19.73

4.24 (27.37%)

11:52
10/15/18
10/15
11:52
10/15/18
11:52
Recommendations
Krystal Biotech analyst commentary  »

Krystal price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

HBAN

Huntington Bancshares

$14.35

-0.02 (-0.14%)

11:50
10/15/18
10/15
11:50
10/15/18
11:50
Options
Huntington Bancshares attracts call buyers »

Huntington Bancshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 25

    Oct

11:50
10/15/18
10/15
11:50
10/15/18
11:50
General news
Treasury's $84 B 3- and 6-month bill sales were mixed, but generally lackluster »

Treasury's $84 B 3-…

OXY

Occidental Petroleum

$73.69

-3.24 (-4.21%)

11:48
10/15/18
10/15
11:48
10/15/18
11:48
Hot Stocks
Occidental confirms it will no longer pursue contract extension for ISND »

Occidental Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

CENX

Century Aluminum

$10.30

0.14 (1.38%)

11:45
10/15/18
10/15
11:45
10/15/18
11:45
Options
Century Aluminum call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

11:45
10/15/18
10/15
11:45
10/15/18
11:45
General news
Former Fed Chair Yellen said 3% growth is great »

Former Fed Chair Yellen…

DUK

Duke Energy

$80.57

0.6 (0.75%)

11:42
10/15/18
10/15
11:42
10/15/18
11:42
Hot Stocks
Duke Energy announces plans for new renewable energy program in South Carolina »

Duke Energy has proposed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

  • 11

    Nov

  • 11

    Nov

ENDP

Endo

$17.62

0.11 (0.63%)

11:35
10/15/18
10/15
11:35
10/15/18
11:35
Options
Endo put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

  • 27

    Nov

11:34
10/15/18
10/15
11:34
10/15/18
11:34
General news
6-Month Bill Auction Total Amount data reported »

6-Month Bill Auction…

11:34
10/15/18
10/15
11:34
10/15/18
11:34
General news
3-Month Bill Auction Total Amount data reported »

3-Month Bill Auction…

LTHM

Livent

$16.11

-0.14 (-0.86%)

11:31
10/15/18
10/15
11:31
10/15/18
11:31
Initiation
Livent initiated  »

Livent initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PX

Praxair

$158.82

2.62 (1.68%)

, LNEGY

Linde

$0.00

(0.00%)

11:27
10/15/18
10/15
11:27
10/15/18
11:27
Hot Stocks
Linde, Praxair announce squeeze-out of remaining Linde shareholders »

Linde (LNEGY) and Praxair…

PX

Praxair

$158.82

2.62 (1.68%)

LNEGY

Linde

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVS

CVS Health

$73.76

-0.73 (-0.98%)

11:25
10/15/18
10/15
11:25
10/15/18
11:25
Conference/Events
Economic Club of Washington, D.C. to hold luncheon meeting »

Luncheon Meeting with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 15

    Oct

  • 15

    Oct

S

Sprint

$6.35

-0.04 (-0.63%)

11:20
10/15/18
10/15
11:20
10/15/18
11:20
Options
Size ratio spread in Sprint »

Size ratio spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 13

    Nov

11:20
10/15/18
10/15
11:20
10/15/18
11:20
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
10/15/18
10/15
11:17
10/15/18
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HBAN

Huntington Bancshares

$14.29

-0.08 (-0.56%)

11:17
10/15/18
10/15
11:17
10/15/18
11:17
Technical Analysis
Technical Take: Huntington Bancshares breaks support »

The shares are down 0.7%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 25

    Oct

PAR

PAR Technology

$20.31

-0.69 (-3.29%)

11:16
10/15/18
10/15
11:16
10/15/18
11:16
Hot Stocks
Voss Capital supports ADW's call for PAR Technology board to pursue alternatives »

Voss Capital, LLC, which…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
10/15/18
10/15
11:16
10/15/18
11:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WB

Weibo

$59.01

-0.67 (-1.12%)

11:15
10/15/18
10/15
11:15
10/15/18
11:15
Options
Weibo put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
10/15/18
10/15
11:15
10/15/18
11:15
General news
Breaking General news story  »

3-Month Bill Auction to…

11:15
10/15/18
10/15
11:15
10/15/18
11:15
General news
Breaking General news story  »

6-Month Bill Auction to…

11:13
10/15/18
10/15
11:13
10/15/18
11:13
Hot Stocks
Breaking Hot Stocks news story  »

Bio Rad Laboratories…

11:10
10/15/18
10/15
11:10
10/15/18
11:10
General news
Treasury announced a $25 B 8-week bill for the inaugural sale Tuesday »

Treasury announced a $25…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.